K-State researchers designing better drug to treat cystic fibrosis
5th Sep 2005, 14:30 GMT
John Tomich, a Kansas State University professor of biochemistry, spends much of his day thinking about how to design a better drug to treat cystic fibrosis. A chronic and progressive disease, cystic fibrosis is usually diagnosed in childhood. It causes mucus to become thick, dry and sticky. The mucus builds up and clogs passages in the lungs, pancreas and other organs in the body.
Latest news from EurekAlert! - Breaking News:
- Scientists capture nanoscale images with short and intense X-ray laser
- Mayo researchers offer evidence people with psoriasis greater risk for developing heart disease
- Mayo Clinic information about accelerated aging among people with rheumatoid arthritis
- ESSP launches project on the effects of global environmental change on human health
- Health inequalities are a growing problem worldwide
- HIV/AIDS linked to extensively drug resistant TB
- Higher death rate for heart attack patients with additional non-cardiac conditions
- Hormone linked to brain's cravings for food and other energy sources
- Key to acute lung injury lies in Ang2 protein
- Propane fuel cell passes muster at Exit Glacier Nature Center